Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro
Leona Yamamoto, Shin-ichi Yamashita, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Toru Shigeoka, Tsuyoshi Horikawa, Yuki Tanaka, Toshihiko Yanase, Daiji Kawanami, Akinori Iwasaki
Topics & Concepts
CanagliflozinMedicineLung cancerA549 cellIn vivoCancer researchEndocrinologyCancer cellCell growthApoptosisInternal medicineCancerPharmacologyType 2 Diabetes MellitusDiabetes mellitusBiologyBiochemistryBiotechnologyDiabetes Treatment and ManagementNeuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology Research